Why U.S. Stocks Are Trading Lower; AZZ Earnings And More
U.S. stocks traded lower this morning as investors digested the recent jobs report for the month of June.
FDA Signs Off Nyxoah’s Genio Trial In Complete Concentric Collapse Patients
The FDA has approved Nyxoah SA’s (NASDAQ:NYXH) Investigational Device Exemption (IDE) to initiate a trial, called ACCCESS, to evaluate the Genio…
Nyxoah Received FDA IDE Approval to Initiate the ACCCESS Study of Genio in Complete Concentric Collapse Patients
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the U.S.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Oppenheimer Initiates Coverage On Nyxoah with Outperform Rating, Announces Price Target of $30
Oppenheimer analyst Suraj Kalia initiates coverage on Nyxoah (NASDAQ:NYXH) with a Outperform rating and announces Price Target of $30.
